CAS 79784-22-8
:Barucainide
- 4-((1,3-Dihydro-6-methyl-4-benzylfuro[3,4-c]pyridin-7-yl)oxy)-N-isopropylbutylamine
- 4-Benzyl-1,3-dihydro-7-(4-(isopropylamino)butoxy)-6-methylfuro(3,4-c)pyridine
- 79784-22-8
- Barucainide [INN]
- 4-[(4-benzyl-6-methyl-1,3-dihydrofuro[3,4-c]pyridin-7-yl)oxy]-N-(propan-2-yl)butan-1-amine
- Barucainidum
- [4-(4-benzyl-6-methyl-1,3-dihydro-furo[3,4-c]pyridin-7-yloxy)-butyl]-isopropyl-amine
- 4-[[1,3-Dihydro-6-methyl-4-(phenylmethyl)furo[3,4-c]pyridin-7-yl]oxy]-N-(1-methylethyl)butan-1-amine
- Barucainide
- Unii-14nfl30yoh
Barucainide
CAS :Produit contrôléApplications Barucainide is an antiarrhythmic drug of class Ib.
References Takanaka, C., Singh, B.: Am. Heart J., 119, 1050 (1990); Brode, E., et al.: Methods Find. Exp. Clin. Pharmacol., 14, 717 (1992);Formule :C22H30N2O2Couleur et forme :NeatMasse moléculaire :354.49Barucainide
CAS :Barucainide is an analog of a protein that has shown promising results as an anticancer agent. It works by inhibiting the activity of kinases, which play a crucial role in tumor growth and progression. Barucainide has been tested on various cancer cell lines, including those derived from human and Chinese hamster urine, and has demonstrated potent apoptosis-inducing effects. This medicinal compound is a promising candidate for the development of kinase inhibitors for cancer therapy. Its unique mechanism of action makes it an attractive option for patients with resistant or refractory cancers. With its potential to target multiple kinases involved in cancer cell proliferation, Barucainide offers new hope for the treatment of this devastating disease.
Formule :C22H30N2O2Degré de pureté :Min. 95%Masse moléculaire :354.5 g/mol

